Normocalcemic hyperparathyroidism and treatment resistant depression

Psychosomatics

Volumn 54, Issue 5, 2013, Pages 493-497

  Grønli, Ole ^a,b   Wynn, Rolf ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM ION; CREATININE; FLUOXETINE; PARATHYROID HORMONE; PHOSPHATE; VENLAFAXINE; VITAMIN D;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; TREATMENT RESISTANT DEPRESSION; URINE RETENTION; VITAMIN D DEFICIENCY;

ADENOMA; AGED; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; PARATHYROID NEOPLASMS;

EID: 84883812666     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2012.10.008     Document Type: Article

References (29)

1. Ambrogini E., Cetani F., Cianferotti L., Vignali E., Banti C., Viccica G., et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007, 92(8):3114-3121.
2. Chan A.K., Duh Q.Y., Katz M.H., Siperstein A.E., Clark O.H. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 1995, 222(3):402-412.
3. Bargren A.E., Repplinger D., Chen H., Sippel R.S. Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism?. J Am Coll Surg 2011, 213(3):410-414.
4. Coker L.H., Rorie K., Cantley L., Kirkland K., Stump D., Burbank N., et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 2005, 242(5):642-650.
5. Adami S., Marcocci C., Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002, 17(Suppl 2):N18-N23.
6. Lowe H., McMahon D.J., Rubin M.R., Bilezikian J.P., Silverberg S.J. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007, 92(8):3001-3005.
7. Silverberg S.J. Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res 2007, 22(Suppl 2):V100-V104.
8. Bollerslev J., Jansson S., Mollerup C.L., Nordenström J., Lundgren E., Tørring O., et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007, 92(5):1687-1692.
9. Walker M.D., McMahon D.J., Inabnet W.B., Lazar R.M., Brown I., Vardy S., et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab 2009, 94(6):1951-1958.
10. Pfitzenmeyer P., Besancenot J.F., Verges B., Cougard P., Lorcerie B., Cercueil J.P., et al. Primary hyperparathyroidism in very old patients. Eur J Med 1993, 2(8):453-456.
11. Weber T., Keller M., Hense I., Pietsch A., Hinz U., Schilling T., et al. Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg 2007, 31(6):1202-1209.
12. Dotzenrath C.M., Kaetsch A.K., Pfingsten H., Cupisti K., Weyerbrock N., Vossough A., et al. Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg 2006, 30(5):680-685.
13. Goyal A., Chumber S., Tandon N., Lal R., Srivastava A., Gupta S. Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery. Ind J Med Sci 2001, 55(12):677-686.
14. Roman S.A., Sosa J.A., Pietrzak R.H., Snyder P.J., Thomas D.C., Udelsman R., et al. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg 2011, 253(1):131-137.
15. Driessen M., Wetterling T., Wedel T., Preuss R. Secondary hyperparathyroidism and depression in chronic renal failure. Nephron 1995, 70(3):334-339.
16. Bagó A.G., Dimitrov E., Saunders R., Seress L., Palkovits M., Usdin T.B., et al. Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 2009, 162(1):128-147.
17. Joborn C., Hetta J., Niklasson F., Rastad J., Wide L., Agren H., et al. Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrinology 1991, 16(4):311-322.
18. Hoogendijk W.J., Lips P., Dik M.G., Deeg D.J., Beekman A.T., Penninx B.W. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008, 65(5):508-512.
19. Zhao G., Ford E.S., Li C., Balluz L.S. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr 2010, 104(11):1696-1702.
20. Kjaergaard M., Joakimsen R., Jorde R. Low serum 25-hydroxyvitamin D levels are associated with depression in an adult Norwegian population. Psychiatry Res 2011, 190(2-3):221-225.
21. Silverberg S.J., Bilezikian J.P. "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. J Clin Endocrinol Metab 2003, 88(11):5348-5352.
22. Bilezikian J.P., Khan A.A., Potts J.T. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the 3rd International Workshop. J Clin Endocrinol Metab 2009, 94(2):335-339.
23. Bilezikian J.P., Silverberg S.J. Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metabol 2010, 54(2):106-109.
24. Chiba Y., Satoh K., Ueda S., Kanazawa N., Tamura Y., Horiuchi T. Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism. Endocr J 2007, 54(3):379-383.
25. Espiritu R.P., Kearns A.E., Vickers K.S., Grant C., Ryu E., Wermers R.A. Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab 2011, 96(11):E1737-E1745.
26. Rao D.S., Phillips E.R., Divine G.W., Talpos G.B. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2004, 89(11):5415-5422.
27. Sakane N., Yoshida T., Umekawa T., Kondo M., Nagoshi Y. A case of primary hyperparathyroidism that had been treated under a diagnosis of depression for 10 years. Psychiatry Clin Neurosci 1995, 49(2):147-149.
28. Watson L.C., Marx C.E. New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. Psychosomatics 2002, 43(5):413-417.
29. Paslakis G., Gilles M., Frankhauser P., Lanczik O., Deuschle M., Frölich L., et al. Two cases of primary hyperparathyroidism with depressive and cognitive symptoms. J Nutr Health Aging 2010, 14(9):798-799.